NCOA3 and breast cancer: The elevated expression levels of nuclear receptor coactivator 3 (ncoa3; AIB1) and human epidermal growth factor receptor 2 (HER2) in breast cancer cells were demonstrated to contribute to tamoxifen resistance (11).